4th Quarter - Report

AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION for AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$344,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 20, 2012 $344,000 Replaced
4th Quarter - Amendment Aug 31, 2016 $344,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Against legislation to repeal the tax on indoor tanning services (HR 2092 and S 1278)

LobbyistCovered position, as disclosed
JOHN E HEDSTROM —
SAMUEL J HEWITT —
JENNIFER MASCHO —
WHITNEY TYLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: H.R. 2092 (112th)

Health Issues HCR

Support legislation for medical liability reform (HR 5) Support for legislation requesting the FDA examine the current classification of indoor tanning beds (HR 1676) Support legislation to repeal the in-office ancillary and physician services exception to the Stark self-referral law for pathology serv FDA consideration of the existing iPledge program; FDA concerns regarding the escalating drug shortages problem

LobbyistCovered position, as disclosed
JOHN E HEDSTROM —
SAMUEL J HEWITT New —
JENNIFER MASCHO —
WHITNEY TYLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 5 (112th), H.R. 1676 (112th)

Medicare/Medicaid MMM

Enacting a permanent repeal of the Medicare Sustainable Growth Rate (SGR) Medicare physician fee schedule and other revisions to Medicare Part B for Calendar Year 2012

LobbyistCovered position, as disclosed
JOHN E HEDSTROM —
SAMUEL J HEWITT —
JENNIFER MASCHO —
WHITNEY TYLER New —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Increase funding for medical research and skin cancer programs in FY 2012 Labor-HHS-appropriations HR 2055 and FY 2012 Dept. of Defense appropriations

LobbyistCovered position, as disclosed
JOHN E HEDSTROM —
SAMUEL J HEWITT New —
JENNIFER MASCHO —
WHITNEY TYLER —

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2055 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.